231 related articles for article (PubMed ID: 32524459)
1. Should Signet Ring Cell Histology Alter the Treatment Approach for Clinical Stage I Gastric Cancer?
Turgeon MK; Gamboa AC; Rupji M; Lee RM; Switchenko JM; El-Rayes BF; Russell MC; Cardona K; Kooby DA; Staley CA; Maithel SK; Shah MM
Ann Surg Oncol; 2021 Jan; 28(1):97-105. PubMed ID: 32524459
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemotherapy
Li Y; Ma FH; Xue LY; Tian YT
World J Gastroenterol; 2020 Feb; 26(8):818-827. PubMed ID: 32148379
[TBL] [Abstract][Full Text] [Related]
3. Improving survival of stage II-III primary gastric signet ring cell carcinoma by adjuvant chemoradiotherapy.
Li Y; Zhu Z; Ma F; Xue L; Tian Y
Cancer Med; 2020 Sep; 9(18):6617-6628. PubMed ID: 32744431
[TBL] [Abstract][Full Text] [Related]
4. [A multi-center retrospective study of perioperative chemotherapy for gastric cancer based on real-world data].
Ding XW; Zheng ZC; Zhao Q; Zhai G; Liang H; Wu X; Zhu ZG; Wang HJ; He QS; He XL; Du YA; Chen LC; Hua YW; Huang CM; Xue YW; Zhou Y; Zhou YB; Wu D; Fang XD; Dai YG; Zhang HW; Cao JQ; Li LP; Chai J; Tao KX; Li GL; Jie ZG; Ge J; Xu ZF; Zhang WB; Li QY; Zhao P; Ma ZQ; Yan ZL; Zheng GL; Yan Y; Tang XL; Zhou X
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):403-412. PubMed ID: 34000769
[No Abstract] [Full Text] [Related]
5. Impact of pCR after neoadjuvant chemotherapy and radical D2 dissection in locally advanced gastric cancers: Analysis of 1001 cases.
Bhandare MS; Gundavda KK; Yelamanchi R; Chopde A; Batra S; Kolhe M; Ramaswamy A; Ostwal V; Deodhar K; Chaudhari V; Shrikhande SV
Eur J Surg Oncol; 2024 Jun; 50(6):108343. PubMed ID: 38640606
[TBL] [Abstract][Full Text] [Related]
6. Impact of Signet-Ring Cell Histology in the Management of Patients with Non-Metastatic Gastric Cancer: Results from a Retrospective Multicenter Analysis Comparing FLOT Perioperative Chemotherapy vs. Surgery Followed by Adjuvant Chemotherapy.
Giampieri R; Baleani MG; Bittoni A; Rastelli F; Catalano V; Del Prete M; Chiorrini S; Pinterpe G; Graziano F; Giorgi FC; Bisonni R; Silva R; Alessandroni P; Mencarini L; Berardi R
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444451
[TBL] [Abstract][Full Text] [Related]
7. Propensity-Score Matched Analysis of Survival Outcomes of Adjuvant Therapy in Stage II-III Signet-Ring Cell Carcinoma of the Colon.
Emile SH; Horesh N; Garoufalia Z; Gefen R; Strassmann V; Wexner SD
Clin Colorectal Cancer; 2024 Mar; 23(1):35-45. PubMed ID: 37980215
[TBL] [Abstract][Full Text] [Related]
8. The Prognostic Value of Signet-Ring Cell Histology in Resected Gastric Adenocarcinoma.
Postlewait LM; Squires MH; Kooby DA; Poultsides GA; Weber SM; Bloomston M; Fields RC; Pawlik TM; Votanopoulos KI; Schmidt CR; Ejaz A; Acher AW; Worhunsky DJ; Saunders N; Swords D; Jin LX; Cho CS; Winslow ER; Cardona K; Staley CA; Maithel SK
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S832-9. PubMed ID: 26156656
[TBL] [Abstract][Full Text] [Related]
9. Signet-ring cell or mucinous histology after preoperative chemoradiation and survival in patients with esophageal or esophagogastric junction adenocarcinoma.
Chirieac LR; Swisher SG; Correa AM; Ajani JA; Komaki RR; Rashid A; Hamilton SR; Wu TT
Clin Cancer Res; 2005 Mar; 11(6):2229-36. PubMed ID: 15788671
[TBL] [Abstract][Full Text] [Related]
10. Signet Ring Cell Histology Confers Worse Overall Survival in Treated Esophageal Adenocarcinoma.
Tang A; Rappaport J; Raja S; Bribriesco AC; Sudarshan M; Siddiqui HU; Raymond D; Murthy SC; Ahmad U
Ann Thorac Surg; 2021 Jan; 111(1):214-222. PubMed ID: 32579884
[TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics and Prognostic Analysis of Patients With Signet Ring Cell Gastric Carcinoma.
Yu JM; Zhan ZW; Zhen JX; Wang XJ; Chen Y; Lin J; Chen L; Chen LZ; Huang YF; Guo ZQ
Technol Cancer Res Treat; 2020; 19():1533033820983812. PubMed ID: 33371800
[TBL] [Abstract][Full Text] [Related]
12. Is preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach?
Heger U; Blank S; Wiecha C; Langer R; Weichert W; Lordick F; Bruckner T; Dobritz M; Burian M; Springfeld C; Grenacher L; Siewert JR; Büchler M; Ott K
Ann Surg Oncol; 2014 May; 21(5):1739-48. PubMed ID: 24419755
[TBL] [Abstract][Full Text] [Related]
13. Signet ring gastric and esophageal adenocarcinomas: characteristics and prognostic implications.
Khan N; Donohoe CL; Phillips AW; Griffin SM; Reynolds JV
Dis Esophagus; 2020 Nov; 33(11):. PubMed ID: 32378712
[TBL] [Abstract][Full Text] [Related]
14. The Proportion of Signet Ring Cell Component in Patients with Localized Gastric Adenocarcinoma Correlates with the Degree of Response to Pre-Operative Chemoradiation.
Charalampakis N; Nogueras González GM; Elimova E; Wadhwa R; Shiozaki H; Shimodaira Y; Blum MA; Rogers JE; Harada K; Matamoros A; Sagebiel T; Das P; Minsky BD; Lee JH; Weston B; Bhutani MS; Estrella JS; Badgwell BD; Ajani JA
Oncology; 2016; 90(5):239-47. PubMed ID: 27046280
[TBL] [Abstract][Full Text] [Related]
15. Phase II/III multicentre randomised controlled trial evaluating a strategy of primary surgery and adjuvant chemotherapy versus peri-operative chemotherapy for resectable gastric signet ring cell adenocarcinomas - PRODIGE 19 - FFCD1103 - ADCI002.
Piessen G; Messager M; Le Malicot K; Robb WB; Di Fiore F; Guilbert M; Moreau M; Christophe V; Adenis A; Mariette C
BMC Cancer; 2013 Jun; 13():281. PubMed ID: 23758655
[TBL] [Abstract][Full Text] [Related]
16. [Gastric signet ring cell adenocarcinoma: A distinct entity].
Tabouret T; Dhooge M; Rouquette A; Brezault C; Beuvon F; Chaussade S; Coriat R
Presse Med; 2014 Apr; 43(4 Pt 1):353-7. PubMed ID: 24440764
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant Therapy Improves Outcomes in Locally Advanced Signet-Ring-Cell Containing Esophagogastric Adenocarcinomas.
Heger U; Sisic L; Nienhüser H; Blank S; Hinz U; Haag GM; Ott K; Ulrich A; Büchler MW; Schmidt T
Ann Surg Oncol; 2018 Aug; 25(8):2418-2427. PubMed ID: 29855828
[TBL] [Abstract][Full Text] [Related]
18. Perioperative chemotherapy is associated with a survival advantage in early stage adenocarcinoma of the pancreatic head.
Lutfi W; Talamonti MS; Kantor O; Wang CH; Liederbach E; Stocker SJ; Bentrem DJ; Roggin KK; Winchester DJ; Marsh R; Prinz RA; Baker MS
Surgery; 2016 Sep; 160(3):714-24. PubMed ID: 27422328
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemoradiation with 5-fluorouracil/leucovorin versus S-1 in gastric cancer patients following D2 lymph node dissection surgery: a feasibility study.
Lee SJ; Sohn TS; Lee J; Park SH; Park JO; Lim DH; Park YS; Lim HY; Choi MG; Lee JH; Bae JM; Kim S; Kang WK
Anticancer Res; 2014 Nov; 34(11):6585-91. PubMed ID: 25368262
[TBL] [Abstract][Full Text] [Related]
20. Impact of ypT, ypN, and Adjuvant Therapy on Survival in Gastric Cancer Patients Treated with Perioperative Chemotherapy and Radical Surgery.
Coimbra FJF; de Jesus VHF; Ribeiro HSC; Diniz AL; de Godoy AL; de Farias IC; Felismino T; Mello CAL; Almeida MF; Begnami MDFS; Dias-Neto E; Riechelmann RSP; da Costa WL
Ann Surg Oncol; 2019 Oct; 26(11):3618-3626. PubMed ID: 31222685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]